Sana Biotechnology Inc.

NASDAQ: SANA · Real-Time Price · USD
3.33
-0.10 (-2.92%)
At close: Aug 15, 2025, 3:59 PM
3.36
0.75%
After-hours: Aug 15, 2025, 07:52 PM EDT

Sana Biotechnology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
127.57M 133.52M 176.76M 253.03M
Short-Term Investments
24.93M 71.68M 247.2M 297.97M
Long-Term Investments
n/a n/a 10.05M 195.88M
Other Long-Term Assets
5.12M 6.37M 9.01M 13.82M
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
8.31M 8.32M 20.47M 7.11M
Total Current Assets
160.81M 213.51M 444.44M 558.1M
Property-Plant & Equipment
135.27M 145.59M 159.4M 161.78M
Goodwill & Intangibles
199.82M 199.82M 199.82M 199.82M
Total Long-Term Assets
340.21M 351.78M 378.28M 571.31M
Total Assets
501.02M 565.3M 822.72M 1.13B
Account Payables
5.21M 4.11M 2.86M 2.22M
Deferred Revenue
n/a n/a n/a 31.48M
Short-Term Debt
n/a n/a 12.39M 9.16M
Other Current Liabilities
300K 23.46M 64.2M 65.47M
Total Current Liabilities
45.43M 64.49M 111.5M 99.23M
Long-Term Debt
n/a n/a 95.86M 101.78M
Other Long-Term Liabilities
123.42M 122.41M 20.18M 98.1M
Total Long-Term Liabilities
205.08M 213.31M 211.9M 301.67M
Total Liabilities
250.52M 277.79M 323.4M 400.9M
Total Debt
94.2M 104.1M 108.25M 110.94M
Common Stock
22K 20K 19K 18K
Retained Earnings
-1.6B -1.34B -1.05B -785.36M
Comprehensive Income
14K -60K -4.33M -1.37M
Shareholders Equity
250.5M 287.51M 499.31M 728.5M
Total Investments
24.93M 71.68M 257.25M 493.85M